The frequency of interferon-gproducing cells reflects alloreactivity against minor histocompatibility antigens
- 1 April 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 75 (8) , 1400-1404
- https://doi.org/10.1097/01.tp.0000064376.78084.50
Abstract
In human leukocyte antigen (HLA)-identical living-related renal transplant recipients, no donor-specific alloreactivity can be detected in regular tests (mixed lymphocyte culture, helper T-lymphocyte precursor frequencies, cytotoxic T-lymphocyte precursor frequencies) to identify patients responding to minor histocompatibility antigens (mHag). We questioned whether a more sensitive method like the Elispot-assay could be more appropriate. Peripheral blood mononuclear cells (PBMC) from 16 HLA-identical living-related kidney transplant patients 3 months (range, 2 weeks to 5 months) after transplantation were tested for the frequency of interferon (IFN)-γ producing cells by the Elispot-assay. PBMC from the recipient were stimulated with irradiated donor PBMC and corrected for backward stimulation. Donor-specific IFN-γ producing cells (pc) in the range of 5 to 115 per million PBMC (median, 30 per million PBMC) were found. To evaluate the frequency of spot forming cells in time, PBMC from six patients who received an HLA-identical renal transplant were stimulated with irradiated donor PBMC before, approximately 3 months after, and 12 months after transplantation. Four patients who received an HLA-mismatched living-related kidney served as positive control. In the HLA-identical group, frequencies in the range of 0 to 10 IFN-γ pc per million PBMC were found before transplantation, 0 to 30 per million PBMC 3 months after transplantation, and 0 to 45 per million PBMC 12 months after transplantation. In the HLA-mismatched group, significantly higher numbers were found: 10 to 480 IFN-γ pc per million PBMC before, 20 to 360 per million PBMC at 3 months, and 30 to 590 per million PBMC 12 months after transplantation. Under immunosuppressive therapy, IFN-γ pc specific for donor mHag can be found after HLA-identical living-related renal transplantation.Keywords
This publication has 10 references indexed in Scilit:
- The DBY gene codes for an HLA-DQ5–restricted human male-specific minor histocompatibility antigen involved in graft-versus-host diseaseBlood, 2002
- General T-cell receptor antagonists to immunomodulate HLA-A2–restricted minor histocompatibility antigen HA-1–specific T-cell responsesBlood, 2002
- The Immunogenicity of a New Human Minor Histocompatibility Antigen Results from Differential Antigen ProcessingThe Journal of Experimental Medicine, 2001
- WITHDRAWAL OF MYCOPHENOLATE MOFETIL IN STABLE RENAL TRANSPLANT RECIPIENTSTransplantation, 2000
- Tetrameric HLA class I–minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host diseaseNature Medicine, 1999
- Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.Journal of Clinical Investigation, 1998
- STEROID WITHDRAWAL IN MYCOPHENOLATE MOFETIL-TREATED RENAL ALLOGRAFT RECIPIENTSTransplantation, 1997
- Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigensThe Lancet, 1990
- Cyclosporine Nephrotoxicity: Pathogenesis, Prophylaxis, Therapy, and PrognosisAmerican Journal of Kidney Diseases, 1986
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983